Imaging of supradiaphragmatic manifestations of extranodal non-Hodgkin's lymphoma [Bildgebende diagnostik supradiaphragmaler manifestationen extranodaler non-Hodgkin-lymphome]

被引：0
作者：
Cohnen M. [1 ]
Saleh A. [1 ]
Germing U. [2 ]
Engelbrecht V. [1 ]
Mödder U. [1 ]
机构：
[1] Institut für Diagnostische Radiologie, Universitätsklinikum Düsseldorf
[2] Klinik für Hämatologie, Onkologie und Klinische Immunologie, Universitätsklinikum Düsseldorf
来源：
Der Radiologe | 2002年 / 42卷 / 12期
关键词：
Computed tomography; CT; Extranodal lymphoma; Lung; Magnetic resonance imaging; MRI; Non-Hodgkin's lymphoma; Orbit; Paranasal sinuses;
D O I：
10.1007/s00117-002-0822-2
中图分类号：
学科分类号：
摘要：
Malignant lymphomas are differentiated into Hodgkin's and non-Hodgkin's-lymphoma (NHL). The following article discusses the imaging of extranodal NHL in supradiaphragmatic localizations. Lymphoma can affect nearly all tissues, and represent a rare entity as primary extranodal NHL. A secondary involvement of non-nodal tissue as consequence of a generalized lymphoproliferative disease is more common, and may be seen as well in HIV-positive patients defining AIDS. As extranodal lymphoma mimick the radiologic appearance of other malignant tumors, direct diagnosis without histologic analysis is often impossible. The article describes typical manifestations of lymphoma of the lungs, the head and neck area including the large glands, and rare localizations as the heart or the breast.
引用
收藏
页码：960 / 969
页数：9
相关论文
共 44 条
  • [1] Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., Lymphoma classification - From controversy to consensus: The R.E.A.L. and WHO classification of lymphoid neoplasms, Ann Oncol, 11, pp. 3-10, (2000)
  • [2] Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., Lister T.A., Bloomfield C.D., The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997, Ann Oncol, 10, pp. 1419-1432, (1999)
  • [3] Meusers P., Brittinger G., R.E.A.L klassifikation von non-Hodgkin lymphomen aus klinisch-onkologischer sicht, Schweiz Rundsch Med Prax, 87, pp. 793-800, (1998)
  • [4] Goldschmidt H., Wallmeier M., Hegenbart U., Haas R., Maligne lymphome. Pathologie, diagnose, therapie, Radiologe, 37, pp. 1-9, (1997)
  • [5] Hermanek P., Hutter R.V.P., Sobin L.H., Wagner G., Wittekind C., TNM-Atlas, pp. S357-S369, (1999)
  • [6] Musshoff K., Klinische staging-klassifikation von non-Hodgkin lymphomen, Strahlentherapie, 153, pp. 218-221, (1977)
  • [7] D'Amore F., Christensen B.E., Brincker H., Pedersen N.T., Thorling K., Hastrup J., Pedersen M., Jensen M.K., Johansen P., Andersen E., Et al., Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas, Eur J Cancer, 27, pp. 1201-1208, (1991)
  • [8] Urquhart A., Berg R., Hodgkin's and non-Hodgkin's lymphoma of the head and neck, Laryngoscope, 111, pp. 1565-1569, (2001)
  • [9] Yasumoto M., Taura S., Shibuya H., Honda M., Primary malignant lymphoma of the maxillary sinus: CT and MRI, Neuroradiology, 42, pp. 285-289, (2000)
  • [10] Chow K.U., Mitrou P.S., Geduldig K., Helm E.B., Hoelzer D., Brodt H.R., Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART), Leuk Lymphoma, 41, pp. 105-116, (2001)
12345